PCM
INSM icon

Prelude Capital Management’s Insmed INSM Stock Holding History

Prelude Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-90,200
Closed -$1.82M – 1962
2018
Q3 		$1.82M Buy
+90,200
New +$2.04M 0.11% 213
2017
Q4 		– Sell
-500
Closed -$16K – 1510
2017
Q3 		$16K Buy
+500
New +$9.52K ﹤0.01% 1357

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Prelude Capital Management's INSM Position: Q2 2026 in Review

Prelude Capital Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 6,775 shares — an estimated $1.11M sold.

Prelude Capital Management first reported a position in INSM in Q1 2014 and held it in 18 quarters. The position peaked at $3.54M in Q3 2018. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Prelude Capital Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 6,775 Insmed shares in Q2 2026, an estimated $1.11M.
  • Prelude Capital Management first reported a position in Insmed in Q1 2014 and held it in 18 quarters.
  • Prelude Capital Management's Insmed position peaked at $3.54M in Q3 2018.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.